web statistics
PRESS ROOM        PUBLICATIONS       CAREERS
KineMed  ► About > Press Room > KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

News & Press Room

Forthcoming Events



Latest News

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

Presentations & Webcasts



 

Press & Public Relations Contact

We are always pleased to assist the press with queries about KineMed. Please visit our press contact page for more information.

Please Contact Us ‣‣

FUNCTIONALLY INTERPRETABLE BIOMARKERS FOR THE NEXT GENERATION OF DISEASE MANAGEMENT

Mr David Fineman  |  President & CEO

Download


5980 Horton Street | Suite 470 | Emeryville, CA 94608 | Tel.: USA [1] 510.655.6525 | Fax: [1] 510.655.6506 | TOLL-FREE: 855.KINEMED | E-mail: info@kinemed.com

 Copyright © 2013 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions